KRAS G12C Inhibitors: New Drugs, A New Hope

J Thorac Oncol. 2024 Dec;19(12):1594-1598. doi: 10.1016/j.jtho.2024.09.1383.

Authors

Surbhi Singhal¹, Shiruyeh Schokrpur¹, David Gandara¹, Jonathan W Riess²

Affiliations

¹ Division of Hematology/Oncology, Department of Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, California.
² Division of Hematology/Oncology, Department of Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, California. Electronic address: [email protected].

PMID: 39645298
DOI: 10.1016/j.jtho.2024.09.1383

No abstract available

Publication types

Editorial